BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35065969)

  • 1. A copper chaperone-mimetic polytherapy for SOD1-associated amyotrophic lateral sclerosis.
    McAlary L; Shephard VK; Wright GSA; Yerbury JJ
    J Biol Chem; 2022 Mar; 298(3):101612. PubMed ID: 35065969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cysteine-reactive small molecule ebselen facilitates effective SOD1 maturation.
    Capper MJ; Wright GSA; Barbieri L; Luchinat E; Mercatelli E; McAlary L; Yerbury JJ; O'Neill PM; Antonyuk SV; Banci L; Hasnain SS
    Nat Commun; 2018 Apr; 9(1):1693. PubMed ID: 29703933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metal cofactor zinc and interacting membranes modulate SOD1 conformation-aggregation landscape in an in vitro ALS model.
    Sannigrahi A; Chowdhury S; Das B; Banerjee A; Halder A; Kumar A; Saleem M; Naganathan AN; Karmakar S; Chattopadhyay K
    Elife; 2021 Apr; 10():. PubMed ID: 33825682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CuATSM Protects Against the In Vitro Cytotoxicity of Wild-Type-Like Copper-Zinc Superoxide Dismutase Mutants but not Mutants That Disrupt Metal Binding.
    Farrawell NE; Yerbury MR; Plotkin SS; McAlary L; Yerbury JJ
    ACS Chem Neurosci; 2019 Mar; 10(3):1555-1564. PubMed ID: 30462490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A copper-deficient form of mutant Cu/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis.
    Tokuda E; Nomura T; Ohara S; Watanabe S; Yamanaka K; Morisaki Y; Misawa H; Furukawa Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2119-2130. PubMed ID: 29551730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOD1 aggregation and ALS: role of metallation states and disulfide status.
    Sheng Y; Chattopadhyay M; Whitelegge J; Valentine JS
    Curr Top Med Chem; 2012; 12(22):2560-72. PubMed ID: 23339308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis.
    Seetharaman SV; Prudencio M; Karch C; Holloway SP; Borchelt DR; Hart PJ
    Exp Biol Med (Maywood); 2009 Oct; 234(10):1140-54. PubMed ID: 19596823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational Disorder of the Most Immature Cu, Zn-Superoxide Dismutase Leading to Amyotrophic Lateral Sclerosis.
    Furukawa Y; Anzai I; Akiyama S; Imai M; Cruz FJ; Saio T; Nagasawa K; Nomura T; Ishimori K
    J Biol Chem; 2016 Feb; 291(8):4144-55. PubMed ID: 26694608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Disulfide Bond, but Not Zinc or Dimerization, Controls Initiation and Seeded Growth in Amyotrophic Lateral Sclerosis-linked Cu,Zn Superoxide Dismutase (SOD1) Fibrillation.
    Chattopadhyay M; Nwadibia E; Strong CD; Gralla EB; Valentine JS; Whitelegge JP
    J Biol Chem; 2015 Dec; 290(51):30624-36. PubMed ID: 26511321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cells Overexpressing ALS-Associated SOD1 Variants Are Differentially Susceptible to CuATSM-Associated Toxicity.
    Brown ML; McAlary L; Lum JS; Farrawell NE; Yerbury JJ
    ACS Chem Neurosci; 2022 Aug; 13(16):2371-2379. PubMed ID: 35900338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and pharmacological chaperones for SOD1.
    Wright GSA
    Biochem Soc Trans; 2020 Aug; 48(4):1795-1806. PubMed ID: 32794552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative misfolding of Cu/Zn-superoxide dismutase triggered by non-canonical intramolecular disulfide formation.
    Anzai I; Tokuda E; Handa S; Misawa H; Akiyama S; Furukawa Y
    Free Radic Biol Med; 2020 Feb; 147():187-199. PubMed ID: 31863908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebselen analogues delay disease onset and its course in fALS by on-target SOD-1 engagement.
    Watanabe S; Amporndanai K; Awais R; Latham C; Awais M; O'Neill PM; Yamanaka K; Hasnain SS
    Sci Rep; 2024 May; 14(1):12118. PubMed ID: 38802492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis.
    Furukawa Y; Kaneko K; Yamanaka K; O'Halloran TV; Nukina N
    J Biol Chem; 2008 Aug; 283(35):24167-76. PubMed ID: 18552350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A faulty interaction between SOD1 and hCCS in neurodegenerative disease.
    Wright GS; Antonyuk SV; Hasnain SS
    Sci Rep; 2016 Jun; 6():27691. PubMed ID: 27282955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and oxidative aggregation.
    Furukawa Y; O'Halloran TV
    J Biol Chem; 2005 Apr; 280(17):17266-74. PubMed ID: 15691826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Metal Binding in the Amyotrophic Lateral Sclerosis-Related Aggregation of Copper-Zinc Superoxide Dismutase.
    Sirangelo I; Iannuzzi C
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28850080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular chaperone activity of CCS restores the maturation of SOD1 fALS mutants.
    Luchinat E; Barbieri L; Banci L
    Sci Rep; 2017 Dec; 7(1):17433. PubMed ID: 29234142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Selenium-based compounds with therapeutic potential for SOD1-linked amyotrophic lateral sclerosis.
    Amporndanai K; Rogers M; Watanabe S; Yamanaka K; O'Neill PM; Hasnain SS
    EBioMedicine; 2020 Sep; 59():102980. PubMed ID: 32862101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-Cell NMR in Human Cells: Direct Protein Expression Allows Structural Studies of Protein Folding and Maturation.
    Luchinat E; Banci L
    Acc Chem Res; 2018 Jun; 51(6):1550-1557. PubMed ID: 29869502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.